DMRTA1 is a transcription factor of the DMRT family located on chromosome 9.1 that functions as a DNA-binding regulator of gene expression with roles in multiple biological contexts. 1 The gene is highly expressed in activated and memory CD8+ T cells, where it modulates early naïve CD8+ T cell activation and supports cytotoxic functionality through granzyme B expression, particularly in secondary lymphoid organs during antiviral responses. 1 In cancer contexts, DMRTA1 has emerged as a significant oncogenic factor. 2 In esophageal squamous cell carcinoma (ESCC), DMRTA1 is upregulated in chemotherapy-resistant tumors and forms a positive feedback loop with SOX2, promoting tumor progression and chemoresistance to cisplatin while facilitating immune escape. 2 DMRTA1 is overexpressed in the solid/pseudopapillary component of solid-tubulocystic intrahepatic cholangiocarcinoma. 3 HBV integration near the DMRTA1 locus (chr9.3) activates the mTOR pathway, contributing to intrahepatic cholangiocarcinoma development. 4 Genome-wide studies identify DMRTA1 genetic variants associated with dental fear and anxiety susceptibility, 5 chemotherapy-induced oral mucositis, 6 and sarcoma survival outcomes. 7 These findings suggest DMRTA1 participates in both immune regulation and cancer-related pathways with potential therapeutic targeting implications.